NCT02153983View on ClinicalTrials.gov

Effects of Colchicine in Non-Diabetic Adults With Metabolic Syndrome

PHASE1/PHASE2CompletedINTERVENTIONAL
Enrollment

77

Participants

Timeline

Start Date

May 31, 2014

Primary Completion Date

August 15, 2018

Study Completion Date

August 15, 2018

Conditions
ObesityMetabolic Disease
Interventions
DRUG

Colchicine 0.6Mg Cap

Colchicine 0.6 mg given twice daily

DRUG

Placebo capsules given

Placebo capsules given twice daily

DRUG

Colchicine 0.6Mg Tab

Open-label colchicine

Trial Locations (1)

20892

National Institutes of Health Clinical Center, 9000 Rockville Pike, Bethesda

All Listed Sponsors
collaborator

National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

NIH

collaborator

National Heart, Lung, and Blood Institute (NHLBI)

NIH

lead

Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)

NIH

NCT02153983 - Effects of Colchicine in Non-Diabetic Adults With Metabolic Syndrome | Biotech Hunter | Biotech Hunter